Noriyuki Ozaki Selected Research

Peripheral Nervous System Diseases (PNS Diseases)

1/2014	Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016).
5/2010	Upregulations of P2X(3) and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriyuki Ozaki Research Topics

Disease

14	Hyperalgesia 01/2022 - 09/2005
9	Pain (Aches) 01/2024 - 09/2005
3	Neuralgia (Stump Neuralgia) 01/2022 - 07/2007
3	Hypersensitivity (Allergy) 01/2022 - 11/2019
3	Myalgia 11/2013 - 11/2008
3	Neoplasms (Cancer) 10/2012 - 09/2005
2	Chronic Pain 01/2024 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 09/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2014 - 05/2010
2	Obesity 01/2010 - 10/2007
2	Body Weight (Weight, Body) 01/2010 - 10/2007
2	Polyuria 05/2009 - 11/2008
1	Neoplasm Metastasis (Metastasis) 02/2024
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 02/2024
1	Botulism 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Rupture 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Glioma (Gliomas) 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Diabetes Mellitus 01/2018
1	Arthritis (Polyarthritis) 09/2017
1	Atrophy 01/2016
1	Carcinoma (Carcinomatosis) 01/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Cold Hypersensitivity 01/2014
1	Musculoskeletal Pain 11/2013
1	Diabetes Insipidus 05/2009
1	Nephrogenic Diabetes Insipidus 11/2008
1	Polydipsia 11/2008
1	Visceral Pain 04/2008
1	Insulin Resistance 03/2007

Drug/Important Bio-Agent (IBA)

3	Analgesics (Analgesic Drugs)IBA 01/2024 - 09/2017
3	Nerve Growth Factor (NGF)IBA 09/2018 - 10/2011
3	Morphine (MS Contin)FDA LinkGeneric 09/2017 - 08/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 01/2014
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2008
2	Acid Sensing Ion ChannelsIBA 11/2019 - 11/2008
2	Ion Channels (Ion Channel)IBA 05/2010 - 11/2008
2	Vasopressins (Vasopressin)IBA 05/2009 - 11/2008
2	capsazepineIBA 08/2008 - 09/2005
2	TRPV Cation ChannelsIBA 09/2006 - 09/2005
1	Cilostazol (Pletal)FDA LinkGeneric 02/2024
1	CalciumIBA 01/2024
1	Designer DrugsIBA 04/2023
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	Clodronic Acid (Clodronate)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Choline (Choline Chloride)IBA 01/2022
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2022
1	CathepsinsIBA 01/2022
1	HhAntag691IBA 01/2022
1	betaninIBA 01/2021
1	CytokinesIBA 11/2019
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 11/2019
1	Neutralizing AntibodiesIBA 11/2019
1	Corticotropin-Releasing HormoneIBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	CuprizoneIBA 01/2019
1	Chemokine ReceptorsIBA 01/2018
1	INCB3344IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	sperm releasing substanceIBA 01/2016
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2016
1	NC-4016IBA 01/2014
1	MicellesIBA 01/2014
1	OxalatesIBA 01/2014
1	PlatinumIBA 01/2014
1	Platinum Compounds (Compounds, Platinum)IBA 01/2014
1	1,2-cyclohexanediamine (dach)IBA 01/2014
1	NitrogenIBA 10/2012
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 10/2011
1	staurosporine aglycone (K252a)IBA 10/2011
1	Cisplatin (Platino)FDA LinkGeneric 05/2010
1	GhrelinIBA 01/2010
1	Neurophysins (Neurophysin I)IBA 05/2009
1	Carrier Proteins (Binding Protein)IBA 05/2009
1	Messenger RNA (mRNA)IBA 05/2009
1	Arginine Vasopressin (Argipressin)IBA 05/2009
1	CarrageenanIBA 11/2008
1	LithiumIBA 11/2008
1	Aquaporin 2IBA 11/2008
1	Ruthenium RedIBA 08/2008
1	Mitogen-Activated Protein KinasesIBA 04/2008
1	Mitogen-Activated Protein Kinase 3IBA 04/2008
1	Protein Kinases (Protein Kinase)IBA 04/2008
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2007
1	Baclofen FDA LinkGeneric 10/2007
1	Indicators and Reagents (Reagents)IBA 10/2007
1	GABA-B Receptor AgonistsIBA 10/2007
1	Neuropeptide YIBA 10/2007
1	Purinergic P2X3 ReceptorsIBA 07/2007
1	melanotan-IIIBA 03/2007

Therapy/Procedure

3	Therapeutics 09/2018 - 07/2007
2	Drug Therapy (Chemotherapy) 02/2024 - 01/2014
2	Ligation 01/2016 - 07/2007
2	Intramuscular Injections 11/2013 - 11/2008
1	Hepatectomy 02/2024
1	Craniotomy 01/2020
1	Injections 11/2013